Clinical trials
Hemoglobin SC Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 7 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ann & Robert H Lurie Children's Hospital of Chicago | 4 |
| Baylor College of Medicine | 3 |
| Novartis Pharmaceuticals | 2 |
| Sangart | 2 |
| St. Jude Children's Research Hospital | 2 |
| Aga Khan University | 1 |
| Cardurion Pharmaceuticals, Inc. | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Dana-Farber Cancer Institute | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobin SC Disease | 32 |
| Anemia, Sickle Cell | 26 |
| Vaso-Occlusive Crises | 7 |
| Hemoglobinopathies | 5 |
| Anemia | 4 |
| Thalassemia | 4 |
| beta-Thalassemia | 3 |
| Acute Chest Syndrome | 1 |
| Acute Pain | 1 |
| COVID-19 | 1 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.